Aurobindo Receives Tentative FDA Approval To Produce Oral Version Of Generic Antiretroviral Abacavir For PEPFAR
Mon, 03 Jul 2006 10:00 PM EST
... FDA on Tuesday granted tentative approval to Indian drug manufacturer Aurobindo Pharma to produce an oral version of the antiretroviral drug abacavir for pediatric use in children ages three months to 13 years under the President's Emergency Plan for AIDS Relief, Reuters reports (Reuters, 6/27). [click link for full article] ...
Related Topics
- Abacavir Oral Solution
- Abacavir tablets
- Lp(a)
- Abacavir, Zidovudine and Lamivudine
- Vaccine Testing & Approval
- Sumatriptan Oral
- Oral Cancer
- Oral Health
- Lamivudine
- Tacrolimus ointment
- Mammography
- Amoxicillin Oral Suspension
- Zidovudine Oral Syrup
- Carcinogens
- Carvedilol
- Tarceva
- Amphetamine and Dextroamphetamine ER
- Potassium cyanide
- Bismuth Subsalicylate Oral Liquid
- Metoprolol Oral

Not Signed In -


